Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • Quality and Safety
Home > Physicians > Geradts, Joseph
Jumbo Large Regular Text:
Print
Physicians

Joseph Geradts, MD, MA

Related Content

Services

  • Pathology Programs

Share

Joseph Geradts, MD, MA

Department / Division
Pathology / Pathology Clinical Services

Address
DUMC 3712
Durham, NC 27710

Office Telephone
919-668-5670

Fax Telephone
919-684-8693

Training
  • MD, University of Chicago Pritzker School of Medicine (Illinois), 1987

Residency
  • Anatomic Pathology, University of California–San Francisco Hospitals, 1987-1989

Fellowship
  • Surgical Pathology, Stanford University Medical Center (California), 1989-1990

Other Training
  • MA, Endocrinology, University of California–Berkeley, 1984

Clinical Interests
Surgical and oncologic pathology, breast pathology including prognostic and predictive markers

Research Interests
Dr. Geradts' primary research focus is on the molecular pathology of breast cancer. His laboratory uses genomic profiling strategies to identify novel candidate breast cancer genes. Dr. Geradts is also interested in biomarker development. He directs the Tissue Core of Duke's Breast Cancer SPORE and collaborates on numerous breast cancer related research projects with other investigators at Duke and elsewhere.

Industry Relationships and Collaborations (What's this?)

This faculty member has no reported relationships with industry.

Representative Publications
Barry, WT; Kernagis, DN; Dressman, HK; Griffis, RJ; Hunter, JD; Olson, JA; Marks, JR; Ginsburg, GS; Marcom, PK; Nevins, JR; Geradts, J; Datto, MB. Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome. Journal of Clinical Oncology. 2010;28:2198-2206. (2010) Abstract

Brown, JQ; Wilke, LG; Geradts, J; Kennedy, SA; Palmer, GM; Ramanujam, N. Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo. Cancer Research. 2009;69:2919-2926. (2009) Abstract

Ramanujam, N; Brown, J; Bydlon, TM; Kennedy, SA; Richards, LM; Junker, MK; Gallagher, J; Barry, WT; Wilke, LG; Geradts, J. Quantitative spectral reflectance imaging device for intraoperative breast tumor margin assessment. 2009;2009:6554-6556. (2009) Abstract

Sood, AK; Wang, J; Mhawech-Fauceglia, P; Jana, B; Liang, P; Geradts, J. Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis. Cancer Epidemiology, Biomarkers and Prevention. 2009;18:1899-1903. (2009) Abstract

Millikan, RC; Newman, B; Tse, CK; Moorman, PG; Conway, K; Dressler, LG; Smith, LV; Labbok, MH; Geradts, J; Bensen, JT; Jackson, S; Nyante, S; Livasy, C; Carey, L; Earp, HS; Perou, CM. Epidemiology of basal-like breast cancer. Breast Cancer Research and Treatment. 2008;109:123-139. (2008) Abstract

Huang, H; Sossey-Alaoui, K; Beachy, SH; Geradts, J. The tetraspanin superfamily member NET-6 is a new tumor suppressor gene. Journal of Cancer Research and Clinical Oncology. 2007;133:761-769. (2007) Abstract

Sood, AK; Saxena, R; Groth, J; Desouki, MM; Cheewakriangkrai, C; Rodabaugh, KJ; Kasyapa, CS; Geradts, J. Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression. Human Pathology. 2007;38:1628-1638. (2007) Abstract

Carey, LA; Perou, CM; Livasy, CA; Dressler, LG; Cowan, D; Conway, K; Karaca, G; Troester, MA; Tse, CK; Edmiston, S; Deming, SL; Geradts, J; Cheang, MC; Nielsen, TO; Moorman, PG; Earp, HS; Millikan, RC. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA: Journal of the American Medical Association. 2006;295:2492-2502. (2006) Abstract

Huang, H; Groth, J; Sossey-Alaoui, K; Hawthorn, L; Beall, S; Geradts, J. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors. Clinical Cancer Research. 2005;11:4357-4364. (2005) Abstract

Varma, G; Varma, R; Huang, H; Pryshchepava, A; Groth, J; Fleming, D; Nowak, NJ; McQuaid, D; Conroy, J; Mahoney, M; Moysich, K; Falkner, KL; Geradts, J. Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York. British Journal of Cancer. 2005;93:699-708. (2005) Abstract

Geradts, J. Abrogation of the RB-p16 tumor suppressor pathway in human lung cancer. Methods in Molecular Medicine. 2003;74:89-99. (2003) Abstract

Wilson, KS; Roberts, H; Leek, R; Harris, AL; Geradts, J. Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues. American Journal of Pathology. 2002;161:1171-1185. (2002) Abstract

Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En Español | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Dec. 12, 2006
Published: Dec. 12, 2006
URL: http://www.dukehealth.org/physicians/joseph_geradts